Prospective Assessment of the Inflammation Parameters in Blood Counts and Blood Serum as prognostic/predictive Parameters for Treatment with Immune Checkpoint-Inhibitors

Schweizer C, Haderlein M, Schubert P, Zhou J, Semrau S, Rutzner S, Gostian AO, Frey B, Donaubauer AJ, Eckstein M, Becker I, Fietkau R, Gaipl U, Hecht M (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Strahlentherapie und Onkologie Urban & Vogel

Publisher: SPRINGER HEIDELBERG

City/Town: HEIDELBERG

Pages Range: S48-S48

Conference Proceedings Title: STRAHLENTHERAPIE UND ONKOLOGIE

Authors with CRIS profile

Claudia Schweizer Department of Radiation Oncology Marlen Haderlein Department of Radiation Oncology Philipp Schubert Medizinische Fakultät Jianguo Zhou Department of Radiation Oncology Sabine Semrau Medizinische Fakultät Sandra Rutzner Department of Radiation Oncology Antoniu-Oreste Gostian Department of Otorhinolaryngology – Head and Neck Surgery Benjamin Frey Department of Radiation Oncology Anna-Jasmina Donaubauer Department of Radiation Oncology Markus Eckstein Institute of Pathology Ina Becker Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie Udo Gaipl Department of Radiation Oncology Markus Hecht Department of Radiation Oncology

How to cite

APA:

Schweizer, C., Haderlein, M., Schubert, P., Zhou, J., Semrau, S., Rutzner, S.,... Hecht, M. (2021). Prospective Assessment of the Inflammation Parameters in Blood Counts and Blood Serum as prognostic/predictive Parameters for Treatment with Immune Checkpoint-Inhibitors. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S48-S48). HEIDELBERG: SPRINGER HEIDELBERG.

MLA:

Schweizer, Claudia, et al. "Prospective Assessment of the Inflammation Parameters in Blood Counts and Blood Serum as prognostic/predictive Parameters for Treatment with Immune Checkpoint-Inhibitors." Proceedings of the STRAHLENTHERAPIE UND ONKOLOGIE HEIDELBERG: SPRINGER HEIDELBERG, 2021. S48-S48.

BibTeX: Download